Personalized health care: gene analysis for your well -being

Personalized health care: gene analysis for your well -being

Changes in health care are imminent and they can be very positive. With a new initiative, Wiener Städtische Versicherung AG and Donau Versicherung AG want to expand their offer and use modern technologies. The introduction of genetic analyzes is the focus of these innovations in order to promote more individual health care.

The two insurance companies integrate two new services into their additional programs "better-life" and "Donau active". The aim of these measures is to adapt health policy to the specific needs of each individual by incorporating genetic information into health proposals. This comes at a time when the need for personalized medicine is constantly growing.

medication check for individual therapies

One of the most important innovations is the "medication check". This service uses genetic analyzes to specifically coordinate the medication to the genetic disposition of customers. With over 2.5 million gene sections examined, the possibility of dosing medication is better to dose medication and to identify potential interactions and intolerances at an early stage.

Sonja Brandtmayer, the Deputy General Director of the city, indicates that almost half of the population use regular medication in Austria. The new check aims to increase the compatibility of the medication and significantly improve the quality of treatment. This happens by minimizing unwanted side effects.

individualized lifestyle recommendations

Another interesting development is the genetic "lifestyle analysis", which not only includes nutrition, but also fitness and mental health. Customers receive tailor -made recommendations based on their genetic predisposition. This analysis makes it possible to develop individual lifestyle recommendations that aim to exploit the full potential in the areas of longevity (durability), performance and general well -being.

Cooperation with Permedio GmbH, a company that specializes in genetics and epigenetics, supports these initiatives. This cooperation ensures that the new services are well -founded and high quality. Permedio is based in Neunkirchen, Lower Austria, and brings the required expertise for the genetic analyzes.

Another important aspect of these new services is data security. According to the official announcement, it is emphasized that the two insurers have no access to their customers' health data. The protection of the personal information of the insured is therefore fully guaranteed. This security is crucial to strengthen customers' trust in the new offers.

Overall, the new services represent an important step towards personalized health care. Users benefit from a more individual approach that takes into account both drug therapy and lifestyle. More details on this topic can be found in a detailed report www.versicherungsjournal.at .